# OnCo record nct07418749 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07418749/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07418749", "NCT07418749" ;
  schema:name "A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer"@en ;
  schema:description "A phase 3 trial testing SHR-A2102 in cervical cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07418749/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07418749> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-03-30" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/recurrent-metastatic-cervical-cancer/> ;
  onco:drugs <https://onco.cc/drugs/shr-a2102/> ;
  onco:companies <https://onco.cc/companies/hengrui/> .